Clinical trial
Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance
NCT04708535 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2017
- Completion date
- August 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammation, insulin resistance, insulin sensitivity, obesity